Literature DB >> 12963934

Intravenous immunoglobulin in livedo vasculitis: a new treatment option?

Stefan Schanz, Anja Ulmer, Gerhard Fierlbeck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12963934     DOI： 10.1067/s0190-9622(03)00785-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

Review 1.  Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.

Authors:  Andreas Steinbrecher; Peter Berlit
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 2.  [Skin diseases due to systemic vasculitides and vasculopathies].

Authors:  S Volc; J C Maier; M Röcken
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

3.  Livedoid thrombotic vasculopathy responding to doxycycline therapy.

Authors:  Matthew S Keller; Jason Lee; Guy F Webster
Journal:  J Clin Aesthet Dermatol       Date:  2008-11

Review 4.  Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review.

Authors:  Yimeng Gao; Hongzhong Jin
Journal:  Ther Adv Chronic Dis       Date:  2022-05-22       Impact factor: 4.970

5.  Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level.

Authors:  Katrin Kofler; Anke Strölin; Vanessa Geiger; Lukas Kofler
Journal:  J Cutan Med Surg       Date:  2021-03-28       Impact factor: 2.092

6.  Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses.

Authors:  Roberta Scarpone; Katharina Meier; Kamran Ghoreschi; Margitta Worm
Journal:  Acta Derm Venereol       Date:  2020-10-21       Impact factor: 3.875
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.